-
1دورية أكاديمية
المؤلفون: Kato M, Tomii K, Hashimoto K, Nezu Y, Ishii T, Jones CE, Kilbride S, Gross AS, Clifton CS, Lipson DA
المصدر: International Journal of COPD, Vol Volume 14, Pp 2849-2861 (2019)
مصطلحات موضوعية: triple therapy, fluticasone furoate, japan, umeclidinium, vilanterol, copd exacerbation, Diseases of the respiratory system, RC705-779
وصف الملف: electronic resource
-
2
المؤلفون: Clifton Cs
المصدر: Quarterly Journal of Studies on Alcohol. 17:89-95
مصطلحات موضوعية: General Medicine
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4048648cb52a77ff7d1a838042cc8bae
https://doi.org/10.15288/qjsa.1956.17.089 -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
المؤلفون: Gross AS; Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline R&D, Sydney, NSW, Australia.; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Harry AC; Global Demographics & Diversity, Global Clinical Sciences and Delivery, GlaxoSmithKline R&D, Upper Providence, PA, USA., Clifton CS; Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline R&D, Sydney, NSW, Australia., Della Pasqua O; Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline R&D, Brentford, UK.; Clinical Pharmacology & Therapeutics Group, School of Pharmacy - University College London, London, UK.
المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jun; Vol. 88 (6), pp. 2700-2717. Date of Electronic Publication: 2022 Feb 17.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Pharmacology, Clinical*, Humans
-
7دورية أكاديمية
المؤلفون: Gross AS; Clinical Pharmacology Modelling & Simulation, GSK R&D, 82 Hughes Ave, Ermington, Sydney, NSW 2115, Australia. annette.s.gross@gsk.com., Goldfrad C; Quantitative Sciences Division, GSK, Uxbridge, UK. caroline.h.goldfrad@gsk.com., Hozawa S; Hiroshima Allergy and Respiratory Clinic, Hiroshima, Japan. hozawa@vesta.ocn.ne.jp., James MH; Medical Affairs, GSK K.K., Tokyo, Japan. mark.h.james@gsk.com., Clifton CS; Clinical Pharmacology Modelling & Simulation, GSK R&D, 82 Hughes Ave, Ermington, Sydney, NSW 2115, Australia. christine.x.perry@gsk.com., Sugiyama Y; Medicines Development Respiratory, GSK K.K., Tokyo, Japan. yutaro.2.sugiyama@gsk.com., Jacques L; Respiratory Medicines Discovery and Development, GSK, Uxbridge, UK. loretta.a.jacques@gsk.com.
المصدر: BMC pulmonary medicine [BMC Pulm Med] 2015 Dec 24; Vol. 15, pp. 165. Date of Electronic Publication: 2015 Dec 24.
نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE
مواضيع طبية MeSH: Ethnicity*, Androstadienes/*administration & dosage , Asthma/*ethnology , Benzyl Alcohols/*administration & dosage , Chlorobenzenes/*administration & dosage , Risk Assessment/*methods, Administration, Inhalation ; Adult ; Asthma/drug therapy ; Asthma/physiopathology ; Dose-Response Relationship, Drug ; Double-Blind Method ; Asia, Eastern/epidemiology ; Female ; Forced Expiratory Volume ; Humans ; Male ; Morbidity/trends ; Severity of Illness Index ; Treatment Outcome